Do we have a new drug for heart rate control in patients with permanent atrial fibrillation? Response
- PMID: 33069614
- PMCID: PMC7556276
- DOI: 10.1016/j.rec.2020.08.016
Do we have a new drug for heart rate control in patients with permanent atrial fibrillation? Response
Comment on
-
Do we have a new drug for heart rate control in patients with permanent atrial fibrillation?Rev Esp Cardiol (Engl Ed). 2020 Dec;73(12):1082-1083. doi: 10.1016/j.rec.2020.07.013. Epub 2020 Sep 18. Rev Esp Cardiol (Engl Ed). 2020. PMID: 32958412 English, Spanish. No abstract available.
References
-
- Fontenla A., Lopez-Gil M., Tamargo-Menendez J. Ivabradine for chronic heart rate control in persistent atrial fibrillation. Design of the BRAKE-AF project. Rev Esp Cardiol. 2020;73:368–375. - PubMed
-
- Fontenla A., Villagraz L., De Juan J., Lozano A., Giacoman S., Lopez-Gil M. Ivabradine as an alternative to AV node ablation in a patient with permanent atrial fibrillation. Rev Esp Cardiol. 2017;70:1019–1020. - PubMed
-
- Fontenla A., Villagraz L., Lozano A., López-Gil M. Ivabradine as an atrioventricular node modulator. Promise or reality? Response. Rev Esp Cardiol. 2017;70:1024. - PubMed
-
- De Ferrari G.M., Maier L.S., Mont L. Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study. Heart Rhythm. 2015;12:872–878. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical